oicr innovation to implementation
to accelerate translational cancer research so that precise, impactful and cost-effective treatments can benefit cancer patients, oicr has implemented a new clinical translation pathway (ctp) to support preclinical, clinical, and convergent research. the ctp consists of four separate funding streams and is currently inviting applications for the innovation to implementation (i2i) funding opportunity which is focused on overcoming barriers to the mobilization, or uptake, of knowledge required to facilitate adoption of research into policy or healthcare. oicr is committed to providing research funding to help support a sustainable health system that enables fair and equitable access to cancer interventions.